Gilead Sciences, Inc.
333 Lakeside Drive
Foster City
California
94404
U.S.A.
Phone:
800-GILEAD-5 or 650-574-3000
Fax:
650-522-5800
|
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
Key Contacts:
John C. Martin, PhD, Chairman and Chief Executive Officer
John F. Milligan, PhD, President and Chief Operating Officer
Norbert W. Bischofberger, PhD, Executive Vice President, Research and Development and Chief Scientific Officer
Kevin Young, Executive Vice President, Commercial Operations
Kristen Metza, Senior Vice President, Human Resources
Susan Hubbard, Vice President, Investor Relations
Amy Flood, Senior Director, Public Affairs
Email:
Ownership:
Web Site:
Gilead Sciences, Inc.
Employees:
3,200
Symbol: GILD
|
|
|
Company News |
Gilead Sciences, Inc. (GILD) to Present at the Lazard Capital Markets 6TH Annual Healthcare Conference on Tuesday, November 17
11/12/2009 9:12:13 AM
More...
|
Concert Pharmaceuticals, Inc. Starts HIV Trial, Bags $12M From GlaxoSmithKline (GSK) to Help Challenge Gilead Sciences, Inc. (GILD)'s (JOBS) Once-Daily Pill
11/9/2009 7:56:18 AM
More...
|
Graceway Pharmaceuticals, LLC Acquires Worldwide Rights to GS 9191 from Gilead Sciences, Inc. (GILD) (JOBS)
11/6/2009 7:39:56 AM
More...
|
Gilead Sciences, Inc. (GILD) to Present at the 18th Annual Credit Suisse Healthcare Conference on Wednesday, November 11
11/5/2009 9:54:10 AM
More...
|
Gilead Sciences, Inc. (GILD) Announces Plans for Phase IV Clinical Trial Evaluating First-Line Combination Therapy Versus Monotherapy in Pulmonary Arterial Hypertension
11/2/2009 9:43:57 AM
More...
|
Gilead Sciences, Inc. (GILD) to Present at the Oppenheimer 0th Annual Healthcare Conference on Tuesday, November 3
11/2/2009 9:30:28 AM
More...
|
Gilead Sciences, Inc. (GILD) Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread(R) For Chronic Hepatitis B
11/2/2009 9:24:56 AM
More...
|
Gilead Sciences, Inc. (GILD)'s (JOBS) Aztreonam for Inhalation Solution to be Reviewed by FDA Anti-Infective Drugs Advisory Committee on December 10, 2009
10/26/2009 6:51:23 AM
More...
|
Gilead Sciences, Inc. (GILD) Profit Up 36 Pct, HIV Sales Disappoint
10/21/2009 9:56:45 AM
More...
|
Gilead Sciences, Inc. (GILD) to Release Third Quarter 2009 Financial Results on Tuesday, October 20, 2009
10/14/2009 10:00:52 AM
More...
|
|
|
|